| Literature DB >> 25407529 |
Lu Kong1, Meng Tang2, Ting Zhang3, Dayong Wang4, Ke Hu5, Weiqi Lu6, Chao Wei7, Geyu Liang8, Yuepu Pu9.
Abstract
Nickel is associated with reproductive toxicity. However, the reproductive toxicity of nickel nanoparticles (Ni NPs) is unclear. Our goal was to determine the association between nickel nanoparticle exposure and reproductive toxicity. According to the one-generation reproductive toxicity standard, rats were exposed to nickel nanoparticles by gavage and we selected indicators including sex hormone levels, sperm motility, histopathology, and reproductive outcome etc. Experimental results showed nickel nanoparticles increased follicle stimulating hormone (FSH) and luteinizing hormone (LH), and lowered etradiol (E2) serum levels at a dose of 15 and 45 mg/kg in female rats. Ovarian lymphocytosis, vascular dilatation and congestion, inflammatory cell infiltration, and increase in apoptotic cells were found in ovary tissues in exposure groups. For male rats, the weights decreased gradually, the ratio of epididymis weight over body weight increased, the motility of rat sperm changed, and the levels of FSH and testosterone (T) diminished. Pathological results showed the shedding of epithelial cells of raw seminiferous tubule, disordered arrangement of cells in the tube, and the appearance of cell apoptosis and death in the exposure group. At the same time, Ni NPs resulted in a change of the reproductive index and the offspring development of rats. Further research is needed to elucidate exposure to human populations and mechanism of actions.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25407529 PMCID: PMC4264223 DOI: 10.3390/ijms151121253
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1SEM (scale bar = 200 nm) (a) and TEM (scale bar = 100 nm) (b) images and particle size distributions of nickel nanoparticles (Ni NPs) of 5 μg/mL (c) and 12.5 μg/mL (d).
Mean body weight and organ weight coefficients for female and male rats.
| Group | Control | Low Dose | Mid Dose | High Dose | Ni MPs |
|---|---|---|---|---|---|
| Female parental rats | |||||
| Mean body weight (g) | |||||
| zero week | 91 ± 6 | 93 ± 7.20 | 93 ± 7 | 93 ± 7 | 92 ± 6 |
| first week | 160 ± 16 | 165 ± 17 | 166 ± 8 | 161 ± 20 | 160 ± 15 |
| fourth week | 235 ± 17 | 234 ± 24 | 233 ± 15 | 231 ± 26 | 229 ± 19 |
| seventh week | 269 ± 19 | 276 ± 26 | 277 ± 19 | 271 ± 25 | 267 ± 22 |
| tenth week | 329 ± 26 | 333 ± 34 | 336 ± 22 | 324 ± 28 | 313 ± 29 |
| thirteenth week | 355 ± 43 | 359 ± 49 | 340 ± 23 | 337 ± 33 | 326 ± 30 * |
| sixteenth week | 322 ± 31 | 337 ± 40 | 325 ± 20 | 322 ± 34 | 316 ± 28 |
| final weight | 307 ± 28 | 313 ± 29 | 314 ± 21 | 307 ± 28 | 300 ± 24 |
| Organ weight coefficient (%) | |||||
| liver | 2.84 ± 0.55 | 2.94 ± 0.52 | 2.65 ± 0.32 | 2.90 ± 0.49 | 2.76 ± 0.41 |
| kidney | 0.65 ± 0.06 | 0.65 ± 0.06 | 0.63 ± 0.05 | 0.65 ± 0.05 | 0.64 ± 0.06 |
| lung | 0.50 ± 0.07 | 0.51 ± 0.08 | 0.53 ± 0.08 | 0.53 ± 0.09 1 | 0.61 ± 0.13 * |
| ovary | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.05 ± 0.01 |
| Male parental rats | |||||
| Mean body weight (g) | |||||
| zero week | 100 ± 7 | 98 ± 9 | 99 ± 7 | 99 ± 10 | 100 ± 8 |
| first week | 196 ± 12 | 196 ± 13 | 195 ± 13 | 185 ± 18 | 182 ± 11 * |
| third week | 303 ± 14 | 301 ± 17 | 293 ± 21 | 284 ± 13 * | 284 ± 13 * |
| fifth week | 370 ± 13 | 376 ± 22 | 365 ± 23 | 357 ± 16 | 345 ± 25 * |
| seventh week | 421 ± 18 | 419 ± 17 | 408 ± 23 | 401 ± 17 * | 388 ± 21 * |
| ninth week | 453 ± 20 | 459 ± 24 | 453 ± 23 | 434 ± 19 * | 432 ± 23 * |
| eleventh week | 487 ± 22 | 486 ± 22 | 477 ± 20 | 460 ± 18 * | 457 ± 28 * |
| Organ weight coefficient (%) | |||||
| liver | 2.13 ± 0.12 | 2.13 ± 0.12 | 2.14 ± 0.14 | 2.16 ± 0.13 | 2.16 ± 0.15 |
| kidney | 0.60 ± 0.05 | 0.60 ± 0.04 | 0.61 ± 0.03 | 0.60 ± 0.03 | 0.61 ± 0.04 |
| lung | 0.35 ± 0.04 | 0.37 ± 0.05 | 0.41 ± 0.05 * | 0.43 ± 0.07 1 | 0.57 ± 0.12 * |
| testis | 0.61 ± 0.04 | 0.63 ± 0.05 | 0.65 ± 0.04 | 0.64 ± 0.03 * | 0.67 ± 0.06 * |
| epididymis | 0.19 ± 0.06 | 0.23 ± 0.01 | 0.23 ± 0.02 * | 0.25 ± 0.02 * | 0.23 ± 0.03 |
* p < 0.05, compared with control group (0 mg/kg body weight (BW)); 1 p < 0.05, compared with Ni MPs (45 mg/kg BW).
Effects of nickel nanoparticles (Ni NPs) on rat sperm motility.
| Group | Control | Low Dose | Mid Dose | High Dose | Ni MPs |
|---|---|---|---|---|---|
| average path velocity (VAP) (μm/s) | 210 ± 15 | 211 ± 14 | 209 ± 10 | 207 ± 8 | 204 ± 8 |
| curvilinear velocity (VCL) (μm/s) | 410 ± 24 | 405 ± 25 | 398 ± 18 | 382 ± 21 * | 384 ± 29 * |
| straight line velocity (VSL) (μm/s) | 145 ± 9 | 144 ± 9 | 144 ± 6 | 141 ± 6 | 140 ± 8 |
| beat cross frequency (BCF) (Hz) | 19 ± 1 | 20 ± 1 * | 20 ± 1 * | 20 ± 1 * | 20 ± 1 * |
| straightness (STR) (%) | 67 ± 1 | 68 ± 1 | 68 ± 1 | 67 ± 1 | 67 ± 1 |
| linearity (LIN) (%) | 37 ± 1 | 37 ± 1 | 36 ± 1 * | 36 ± 1 * | 36 ± 1 * |
| amplitude of lateral head displacement (ALH) (μm) | 18 ± 1 | 18 ± 0 | 19 ± 1 | 19 ± 1 | 19 ± 1 |
| elongation (ELON) (%) | 68 ± 1 | 69 ± 1 | 68 ± 2 | 68 ± 1 | 68 ± 2 |
* p < 0.05, compared with control group.
Figure 2Effects of Ni NPs on serum hormone concentrations in rats. Follicle stimulating hormone (FSH) in females (A); Luteinizing hormone (LH) in females (B); Estradiol (E2) in females (C); FSH in males (D); LH in males (E); Testosterone (T) in males (F). Serum hormone concentrations were measured by ELISA. Values represent the mean ± SD (n = 7). * p < 0.05, compared with control group (0 mg/kg BW); 1 p < 0.05, compared with Ni MPs (45 mg/kg BW).
Figure 3Effects of Ni NPs on histopathology of ovaries in female rats. The control group (A); 15 mg/kg BW (B); 45 mg/kg (C–E); Ni MPs group (F). Original magnification was 100×, 200× and 400× (100× refers to picture A, B and C; 200× refers to picture D and E; 400× refers to picture F). The arrow on (B) and (C) points to vascular dilatation and congestion, on (D) it points to Lymphocytes, on (E) it points to luteal cells, and on (F) it points to eosinophils and inflammatory cells.
Figure 4The testicular histopathological changes of the male rats. The control group (A); 45 mg/kg BW (B–D). Original magnification 200× and 400× (200× refers to picture A, B and C; 400× refers to picture D). The arrow on (C) points to disordered arrangement of cells in the tube and on (D) it points to cell apoptosis.
Effects of Ni NPs on the rats reproductive index (%).
| Group | Mating Success Rate | Pregnancy Rate | Live Birth Rate | Birth Survival Rate | Feeding Survival Rate |
|---|---|---|---|---|---|
| control | 100 (20/20) | 100 (20/20) | 100 (20/20) | 94 (185/196) | 79 (147/185) |
| low dose | 90(18/20) | 90 (18/20) | 100 (18/18) | 86 (171/198) * | 73 (125/171) |
| mid dose | 80 (16/20) | 80 (16/20) | 100 (16/16) | 75 (142/190) * | 65 (93/142) * |
| high dose | 80 (16/20) | 80 (16/20) | 100 (16/16) | 67 (104/156) *,1 | 64 (67/104) *,1 |
| Ni MPs | 90 (18/20) | 90 (18/20) | 100 (18/18) | 82 (174/211) * | 43 (75/174) * |
* p < 0.05, compared with control group; 1 p < 0.05, compared with Ni MPs (45 mg/kg BW).
Body weight changes of pup rats during the experiment (g).
| Group | Birthday | The 4th Day | The 7th Day | The 14th Day | The 21th Day |
|---|---|---|---|---|---|
| Control | 7 ± 1 | 11 ± 2 | 16 ± 3 | 31 ± 3 | 50 ± 5 |
| Low dose | 7 ± 1 | 10 ± 2 * | 15 ± 3 | 27 ± 5 * | 48 ± 5 |
| Mid dose | 7 ± 0 | 10 ± 2 * | 14 ± 3 * | 25 ± 7 * | 46 ± 6 * |
| High dose | 7 ± 0 | 10 ± 2 | 14 ± 2 | 24 ± 2 * | 42 ± 6 * |
| Ni MPs | 7 ± 0 | 9 ± 2 * | 13 ± 3 * | 26 ± 2 * | 45 ± 7 * |
* p < 0.05, compared with control group.
Figure 5Schematic representation of the hypothalamic–pituitary–gonadal (HPG) axes.